Crowdonomics
WatchlistPortfolio
All companies
AUDICUS logo

AUDICUS

Operating

Audicus, Inc.

Healthcare · Founded 2010

Visit website

Pioneer in telehealth for hearing loss, providing customized hearing aids and care for 70% less

Post-money valuation ⓘ
$65.3M
As of May 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$10,381,167
Crowd $299K · Private $10.1M · 5 rounds since 2013
Latest share price
$5.6225
Reg CF · Preferred Stock · May 2024 offering price

Financials

FY2022–FY2024 · from SEC filings · hover any figure for its source
$10.7M
−$877K
2022
$11.9M
−$1.1M
2023
$13.6M
−$1.9M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed*
FY2023 unaudited
FY2024 unaudited
Income statement
Revenue
$10,677,268
$11,904,482
$13,588,085
Cost of goods sold
$2,443,891
$2,614,990
$2,811,262
Gross margin
77%
78%
79%
Net income
-$877,141
-$1,102,087
-$1,859,306
Taxes paid
$0
$0
$8,073
Balance sheet
Cash
$72,700
$807,644
$1,152,283
Accounts receivable
$428,579
$358,861
$1,053,121
Total assets
$1,104,401
$1,786,512
$3,902,420
Short-term debt
$4,519,574
$1,747,814
$3,428,124
Long-term debt
$0
$16,564
$2,750,000
Total liabilities
$4,519,574
$1,764,378
$6,178,124
Other
Headcount
—
63
89

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$65.0M
pre-money
Reg CF · Preferred · May 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Rule 506(b) · Debt · Aug 2024Closed
Raised $200KInvestors 2
Reg CF · Preferred Stock · May 2024Closedvia WeFunder
Raised $299.5K / $1.2MInvestors 197Post-money $65.3M
Rule 506(b) · Equity · Nov 2023Closed
Raised $4.1MInvestors 26
Rule 506(b) · Equity · Jan 2017Closed
Raised $4.2MInvestors 52
Rule 506(b) · Debt · Oct 2013Closed
Raised $1.6MInvestors 35

Team

3 people
Patrick FreulerFounder
CEO/Founder
Andre Sequin
CFO
Stephen Romine
COO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 2 annual reports (FY2024–FY2025)

197 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMar 21, 20250001670254-25-000215
    EDGAR
  • Form DSep 10, 20240001606258-24-000001
    EDGAR
  • Form CApr 26, 20240001670254-24-000450
    EDGAR
  • Form DDec 12, 20230001606258-23-000002
    EDGAR
  • Form DFeb 14, 20170001606258-17-000003
    EDGAR
  • Form DApr 30, 20140001606258-14-000001
    EDGAR
Source: ManualCIK 0001606258Share price $5.6225

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.